Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;82:1449-1466

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Unger, E. F.
Right arrow Articles by Epstein, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Unger, E. F.
Right arrow Articles by Epstein, S. E.

Circulation, Vol 82, 1449-1466, Copyright © 1990 by American Heart Association


ARTICLES

Creation of anastomoses between an extracardiac artery and the coronary circulation. Proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium

EF Unger, CD Sheffield and SE Epstein
Laboratory of Experimental Physiology and Pharmacology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

The purpose of this investigation was to determine whether blood vessels could develop de novo between an extracardiac artery and a collateral-dependent zone of the heart and to quantify the nutritive blood flow afforded by the new vessels. We also adapted the preparation so that angiogenically active agents could be chronically administered directly to the site of neovascularization in subsequent studies. To induce neovascularization between a systemic artery and the coronary circulation, the left internal mammary artery (IMA) was implanted in an intramyocardial tunnel in proximity to the left anterior descending coronary artery (LAD). A tube situated in the distal IMA connected to an implanted pump provided for continuous intra-arterial infusion at the site of angiogenesis. During the same procedure, an ameroid constrictor was placed on the proximal LAD, rendering its perfusion territory collateral dependent during a 2-3 week period. After 8 weeks, the functional capacity of the anastomoses established between the implanted IMA and the LAD territory was assessed by determining regional myocardial blood flow under basal conditions, during adenosine- induced vasodilatation, and during differential occlusions of the IMA and left circumflex coronary artery (LCCA). For all dogs, IMA occlusion decreased maximal LAD territory flow from 1.31 +/- 0.11 to 1.16 +/- 0.10 ml/min/g (p less than 0.005). Occlusion of the LCCA decreased LAD zone flow to 0.73 +/- 0.12 ml/min/g, whereas occlusion of the IMA in addition to the LCCA further decreased LAD zone flow to 0.42 +/- 0.11 ml/min/g (p less than 0.02). The IMA provided measurable nutritive blood flow in seven of 12 dogs, and in these dogs, the artery provided 30.0 +/- 2.5% of total LAD zone collateral conductance under conditions of maximal vasodilatation (range, 23-42%). We conclude that angiogenesis can occur between an implanted internal mammary artery and the native coronary circulation in dogs, providing modest nutritive blood flow to a collateral-dependent region. Further studies will be necessary to determine whether direct, local infusion of angiogenically active factors can enhance neovascularization and whether sufficient flow can be reliably supplied to make some variant of this approach clinically applicable.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Takaba, C. Jiang, S. Nemoto, Y. Saji, T. Ikeda, S. Urayama, T. Azuma, A. Hokugo, S. Tsutsumi, Y. Tabata, et al.
A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: Evolving concept of biologic coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 891 - 899.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. F Unger
Experimental evaluation of coronary collateral development
Cardiovasc Res, February 16, 2001; 49(3): 497 - 506.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Fujita
Heparin and angiogenic therapy
Eur. Heart J., February 2, 2000; 21(4): 270 - 274.
[PDF]


Home page
Ann. Thorac. Surg.Home page
P. Whittaker, J. C.-C. Tsang, and R. C.-J. Chiu
Myocardial revascularization.
Ann. Thorac. Surg., June 1, 1996; 61(6): 1874 - 1875.
[Full Text]


Home page
CirculationHome page
P. Whittaker, K. Rakusan, and R. A. Kloner
Transmural Channels Can Protect Ischemic Tissue : Assessment of Long-term Myocardial Response to Laser- and Needle-MadeChannels
Circulation, January 1, 1996; 93(1): 143 - 152.
[Abstract] [Full Text]


Home page
Arch SurgHome page
M. Hockel, K. Schlenger, S. Doctrow, T. Kissel, and P. Vaupel
Therapeutic Angiogenesis
Arch Surg, April 1, 1993; 128(4): 423 - 429.
[Abstract] [PDF]


Home page
ScienceHome page
A Yanagisawa-Miwa, Y Uchida, F Nakamura, T Tomaru, H Kido, T Kamijo, T Sugimoto, K Kaji, M Utsuyama, C Kurashima, et al.
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
Science, September 4, 1992; 257(5075): 1401 - 1403.
[Abstract] [PDF]